ASCENTAGE PHARMA GROUP INTERNATIONALAAPGEarnings & Financial Report
Nasdaq
AAPG Q4 2025 Key Financial Metrics
营收
$574.1K
毛利润
N/A
营业利润
N/A
净利润
N/A
毛利率
N/A
营业利润率
N/A
净利率
N/A
同比增长
N/A
资金流向
ASCENTAGE PHARMA GROUP INTERNATIONAL Q4 2025 Financial Summary
ASCENTAGE PHARMA GROUP INTERNATIONAL reported revenue of $574.1K for Q4 2025, with a net profit of N/A (N/A margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $574.1K |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2025 |
ASCENTAGE PHARMA GROUP INTERNATIONAL Quarterly Revenue & Net Profit History
ASCENTAGE PHARMA GROUP INTERNATIONAL quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $574.1K | — | N/A | N/A |
| Q2 2025 | $32.6M | — | N/A | N/A |
利润表
| Q2 2025 | Q4 2025 | |
|---|---|---|
| 营收 | $32.6M | $574120 |
| 同比增长 | N/A | N/A |
资产负债表
| Q2 2025 | Q4 2025 | |
|---|---|---|
| 总资产 | N/A | N/A |
| 总负债 | N/A | N/A |
| 股东权益 | N/A | N/A |
现金流量表
No data available for this period